Characterization of nerve growth factor-dependent herpes simplex virus latency in neurons in vitro
- PMID: 2826804
- PMCID: PMC250548
- DOI: 10.1128/JVI.62.2.393-399.1988
Characterization of nerve growth factor-dependent herpes simplex virus latency in neurons in vitro
Abstract
Primary sympathetic neuronal cultures were maintained for up to 5 weeks after inoculation with herpes simplex virus (HSV) without evidence of viral infection. Treatment with acyclovir for the first 7 days after viral inoculation prevented lytic infections in 100% of the cultures and resulted in viral latency in 100% of the cultures; reactivation occurred as the result of nerve growth factor (NGF) deprivation. Treatment of the cultures with several different inhibitors of viral DNA polymerase (acyclovir, aphidicolin, and phosphonoacetic acid) for 7 days after viral inoculation did not prevent the establishment of latency, which suggests that viral DNA replication was not required. During the latent phase of the infection, viral antigens were not detected with HSV-specific immunohistochemistry. However, 24 h after NGF deprivation, viral antigens were detected in essentially all of the neurons, indicating that the majority of neurons harbored latent HSV. The establishment of latency was not strain or type specific since latency was established with HSV type 2 and four strains of HSV type 1 and reactivation occurred in response to NGF deprivation.
Similar articles
-
Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro.J Virol. 1987 Jul;61(7):2311-5. doi: 10.1128/JVI.61.7.2311-2315.1987. J Virol. 1987. PMID: 3035230 Free PMC article.
-
DLK-Dependent Biphasic Reactivation of Herpes Simplex Virus Latency Established in the Absence of Antivirals.J Virol. 2022 Jun 22;96(12):e0050822. doi: 10.1128/jvi.00508-22. Epub 2022 May 24. J Virol. 2022. PMID: 35608347 Free PMC article.
-
HSV Latency In Vitro : In Situ Hybridization Methods.Methods Mol Med. 1998;10:317-26. doi: 10.1385/0-89603-347-3:317. Methods Mol Med. 1998. PMID: 21374238
-
Viral, neuronal and immune factors which may influence herpes simplex virus (HSV) latency and reactivation.Microb Pathog. 1993 Aug;15(2):83-91. doi: 10.1006/mpat.1993.1059. Microb Pathog. 1993. PMID: 8255209 Review. No abstract available.
-
Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds.Am J Med. 1982 Jul 20;73(1A):138-42. doi: 10.1016/0002-9343(82)90079-1. Am J Med. 1982. PMID: 6285703 Review.
Cited by
-
Induction of Transcription Factor Early Growth Response Protein 1 during HSV-1 Infection Promotes Viral Replication in Corneal Cells.Br Microbiol Res J. 2013 Oct 1;3(4):706-723. doi: 10.9734/BMRJ/2013/4817#sthash.mv5smQhR.dpuf. Br Microbiol Res J. 2013. PMID: 25264522 Free PMC article.
-
The molecular basis of herpes simplex virus latency.FEMS Microbiol Rev. 2012 May;36(3):684-705. doi: 10.1111/j.1574-6976.2011.00320.x. Epub 2012 Jan 10. FEMS Microbiol Rev. 2012. PMID: 22150699 Free PMC article. Review.
-
Entry of herpes simplex virus type 1 into primary sensory neurons in vitro is mediated by Nectin-1/HveC.J Virol. 2003 Mar;77(5):3307-11. doi: 10.1128/jvi.77.5.3307-3311.2003. J Virol. 2003. PMID: 12584355 Free PMC article.
-
Enhancement by TNF-alpha of reactivation and replication of latent herpes simplex virus from trigeminal ganglia of mice.Arch Virol. 1995;140(6):987-92. doi: 10.1007/BF01315409. Arch Virol. 1995. PMID: 7611887
-
Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity.J Virol. 1999 Jan;73(1):519-32. doi: 10.1128/JVI.73.1.519-532.1999. J Virol. 1999. PMID: 9847358 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources